G Form 144 Filing — Insider Plans to Sell 18,218 Genpact Shares

Rhea-AI Filing Summary

Genpact Limited (G) filing a Form 144 notifies the proposed sale of 18,218 common shares through Morgan Stanley Smith Barney LLC on the NYSE with an aggregate market value of $810,701.00. The shares were granted as performance shares and were acquired in two tranches: 11,351 on 01/10/2022 and 6,867 on 01/10/2023. The filing lists 174,270,076 shares outstanding for the class and indicates no reported sales by the seller in the past three months. The notice includes the seller’s representation that they are not aware of undisclosed material adverse information.

Positive

• Regulatory compliance: The filer provided required Rule 144 disclosure including broker, share count, and acquisition details
• Transparency: The filing states the seller has no undisclosed material adverse information and reports no sales in the past three months

Negative

• Insider sale: A proposed disposition of 18,218 common shares valued at $810,701 is reported

Insights

Securities Analyst

TL;DR: A routine insider notice to sell a small block of performance shares, disclosed pursuant to Rule 144.

The Form 144 reports a proposed sale of 18,218 shares valued at $810,701 via Morgan Stanley Smith Barney on the NYSE. The shares originated from performance awards granted in 2022 and 2023. Given the reported class outstanding of 174,270,076 shares, the proposed sale represents a de minimis fraction of the outstanding common stock. The filing follows disclosure requirements and includes the standard representation about lack of undisclosed material adverse information.

Corporate Governance Expert

TL;DR: Compliance-focused disclosure of planned insider sale; procedural, not materially transformative.

The document is a procedural Rule 144 notice specifying the broker, number of shares, acquisition dates, and nature of acquisition (performance shares). It confirms no aggregated sales by the seller in the prior three months and includes the statutory signature attestations. There is no indication of any change in control, governance action, or material operational development disclosed here.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	18218	810701.00	174270076	08/21/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	01/10/2022	Performance Shares	Issuer			11351	01/10/2022	Not Applicable
Common	01/10/2023	Performance Shares	Issuer			6867	01/10/2023	Not Applicable

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does Genpact's Form 144 filed under ticker G disclose?

The Form 144 discloses a proposed sale of 18,218 common shares via Morgan Stanley Smith Barney on the NYSE with an aggregate market value of $810,701.00.

When were the shares to be sold originally acquired?

The shares were acquired as performance shares on 01/10/2022 (11,351 shares) and 01/10/2023 (6,867 shares).

How many Genpact shares are outstanding according to the filing?

The filing reports 174,270,076 shares outstanding for the common class.

Did the filer report any sales in the past three months?

The filing states Nothing to Report for securities sold during the past three months by the person for whose account the securities are to be sold.

Through which broker will the proposed sale occur?

The designated broker is Morgan Stanley Smith Barney LLC, Executive Financial Services, 1 New York Plaza, 8th Floor, New York, NY 10004.